4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001214659-24-005217
Chairman and CEO gave up 25,710 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KAZIMI A J Chairman and CEO | 2024-03-23 | Shares withheld for taxes | −25,710 | $1.81 | $46,535 | 5,695,557 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KAZIMI A J Chairman and CEO | 2024-03-25 | Grant or award · Options (right to buy) | +100,000 | 368,000 | D: show line 2 in the form |
Loading xslF345X05/marketforms-65385.xml…